Cidara Therapeutics (CDTX) Short Interest Ratio & Short Volume

Short interest is the volume of Cidara Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 8,200 shares of CDTX short. Learn More on Cidara Therapeutics' current short interest.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cidara Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Cidara Therapeutics saw a decline in short interest in April. As of April 15th, there was short interest totaling 8,200 shares, a decline of 95.8% from the previous total of 195,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cidara Therapeutics: AVROBIO, Inc. (0.36%), Genenta Science S.p.A. (0.02%), Entera Bio Ltd. (0.31%), Aligos Therapeutics, Inc. (0.87%), Turnstone Biologics Corp. (4.76%), Quince Therapeutics, Inc. (6.21%), Ikena Oncology, Inc. (5.48%), OKYO Pharma Limited (0.50%), Elutia Inc. (0.19%), Cyclo Therapeutics, Inc. (0.47%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling CDTX is an investing strategy that aims to generate trading profit from Cidara Therapeutics as its price is falling. CDTX shares are trading up $0.87 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cidara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CDTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CDTX, twice per month. The most recent reporting period available is April, 15 2024.